ACB vs USNA: stock comparison and AI forecast
Aurora Cannabis Inc (ACB) and Usana Health Sciences Inc (USNA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ACB Aurora Cannabis Inc
- Price
- $5.24 +52.8% · 6M
- Market Cap
- $296M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
USNA Usana Health Sciences Inc
- Price
- $13.86 -28.8% · 6M
- Market Cap
- $256M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ACB is 1.2 times larger than USNA by market capitalization ($296M against $256M).
- Over the last six months ACB returned +52.8% and USNA -28.8%.
- Both companies share the SEC industry classification Medicinal Chemicals & Botanical Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ACB | USNA |
|---|---|---|
| Market Cap | $296M | $256M |
| P/B Ratio | – | 0.49x |
| EPS | $-7.26 | $-1.10 |
| Book Value/Share | – | $28.49 |
| Revenue/Share | $11.70 | $49.43 |
| FCF/Share | – | $0.86 |
Profitability & Margins
| Metric | ACB | USNA |
|---|---|---|
| ROE | – | -4.2% |
| ROA | – | -3.1% |
| ROIC | – | -0.2% |
| Gross Margin | 37.0% | 77.5% |
| Operating Margin | -46.8% | -0.1% |
| Net Margin | – | -2.4% |
| EBT Margin | -215.2% | 0.3% |
| Tax Rate | 0.7% | 1253.3% |
Financial Health
| Metric | ACB | USNA |
|---|---|---|
| Current Ratio | – | 2.66x |
| Quick Ratio | – | 1.84x |
| D/E Ratio | – | 0.25x |
| Financial Leverage | – | 1.34x |
| Interest Coverage | – | -86.6x |
| Working Capital | – | $175M |
Cash Flow
| Metric | ACB | USNA |
|---|---|---|
| Operating Cash Flow | -$200M | $28M |
| Free Cash Flow | – | $16M |
| Capital Spending | – | -$12M |
| OCF Growth YoY | – | -57.5% |
| FCF Growth YoY | – | -75.7% |
| FCF/Sales | – | 1.7% |
| CapEx/Sales | – | 1.3% |
Operational Efficiency
| Metric | ACB | USNA |
|---|---|---|
| Asset Turnover | – | 1.30x |
| Receivables Turnover | – | 273.7x |
| Inventory Turnover | – | 2.4x |
| Fixed Assets Turnover | – | 9.7x |
| Days Sales Outstanding | – | 1 days |
| Days Inventory | – | 153 days |
| Payables Period | – | 27 days |
| Cash Conversion Cycle | – | 127 days |
Income Statement
| Metric | ACB | USNA |
|---|---|---|
| Total Revenue | $662M | $913M |
| Operating Income | -$310M | -$1M |
| Net Income | – | -$22M |
| R&D Expense | $16M | – |
| SG&A Expense | – | $335M |
| Cost of Goods Sold | – | $206M |
Dividend & Shareholder Information
| Metric | ACB | USNA |
|---|---|---|
| Shares Outstanding | 57M | 18M |
| Net Income Growth | – | -155.0% |
| EPS Growth | – | -244.7% |
ACB vs USNA: stock comparison and AI forecast
Which is bigger, ACB or USNA?
ACB is 1.2 times larger than USNA by market capitalization ($296M against $256M).
Which stock performed better over the last six months, ACB or USNA?
Over the last six months ACB returned +52.8% and USNA -28.8%.
Which one does Intratio's AI model rank higher, ACB or USNA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.